Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2641747-54-6
2. Chembl5314463
3. Schembl25240538
4. Gtpl12393
5. Glxc-26887
6. Ex-a8314
7. Da-53430
8. Hy-152848
9. Cs-0641191
10. Structure Z25-2 [wo2021083167a1]
11. (4ar,8m)-11-chloro-10-(2-fluoro-6-hydroxyphenyl)-6-methyl-8-[2-(propan-2-yl)-4-methylpyridin-3-yl]-3-prop2-enoyl-2,3,4,4a,6,8-hexahydro-1hpyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione
Molecular Weight | 617.1 g/mol |
---|---|
Molecular Formula | C32H30ClFN6O4 |
XLogP3 | 3.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 110 |
Heavy Atom Count | 44 |
Formal Charge | 0 |
Complexity | 1220 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?